Gender Differences in Prescribing Among Veterans Diagnosed with Posttraumatic Stress Disorder
Open Access
- 27 June 2013
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of General Internal Medicine
- Vol. 28 (S2), 542-548
- https://doi.org/10.1007/s11606-012-2260-9
Abstract
OBJECTIVE The Department of Veterans Affairs (VA) and Department of Defense (DoD) issued a revised posttraumatic stress disorder (PTSD) Clinical Practice Guideline (CPG) in 2010 with specific pharmacotherapy recommendations for evidence-based quality care. The authors examined prescribing frequencies over an 11-year period prior to the release of the new guideline to determine gender differences in pharmacotherapy treatment in veterans with PTSD. METHOD National administrative VA data from 1999 to 2009 were used to identify veterans with PTSD using ICD-9 codes extracted from inpatient discharges and outpatient clinic visits. Prescribing of antidepressants, antipsychotics and hypnotics was determined for each year using prescription drug files. RESULTS Women were more likely than men to receive medication across all classes except prazosin where men had higher prescribing frequency. The proportion of women receiving either of the first-line pharmacotherapy treatments for PTSD, selective serotonin reuptake inhibitors (SSRI) and serotonin-norepinephrine reuptake inhibitors (SNRI), increased from 56.4 % in 1999 to 65.7 % in 2009, higher rates than seen in men (49.2 % to 58.3 %). Atypical antipsychotic prescriptions increased from 14.6 % to 26.3 % and nonbenzodiazepine hypnotics increased from 3.8 % to 16.9 % for women, higher frequencies than seen in men for both medications (OR = 1.31, 1.43 respectively). The most notable gender discrepancy was observed for benzodiazepines where prescriptions decreased for men (36.7 % in 1999 to 29.8 % in 2009) but steadily increased for women from 33.4 % to 38.3 %. CONCLUSION A consistent pattern of increased prescribing of psychotropic medications among women with PTSD was seen compared to men. Prescribing frequency for benzodiazepines showed a marked gender difference with a steady increase for women despite guideline recommendations against use and a decrease for men. Common co-occurring disorders and sleep symptom management are important factors of PTSD pharmacotherapy and may contribute to gender differences seen in prescribing benzodiazepines in women but do not fully explain the apparent disparity.Keywords
This publication has 17 references indexed in Scilit:
- Prevalence and trends of benzodiazepine use among Veterans Affairs patients with posttraumatic stress disorder, 2003–2010Drug and Alcohol Dependence, 2012
- Prescribing Trends in Veterans With Posttraumatic Stress DisorderThe Journal of Clinical Psychiatry, 2012
- Hypnotics' association with mortality or cancer: a matched cohort studyBMJ Open, 2012
- Declining Benzodiazepine Use in Veterans With Posttraumatic Stress DisorderThe Journal of Clinical Psychiatry, 2011
- Benzodiazepines revisited—will we ever learn?Addiction, 2011
- New Women Veterans in the VHA: A Longitudinal ProfileWomen's Health Issues, 2011
- Pharmacologic Treatment of Posttraumatic Stress Disorder Among Privately Insured AmericansPsychiatric Services, 2008
- Pharmacotherapy of PTSD in the U.S. Department of Veterans AffairsThe Journal of Clinical Psychiatry, 2008
- Twelve-Month Use of Mental Health Services in the United StatesArchives of General Psychiatry, 2005
- Sex differences among recipients of benzodiazepines in Dutch general practice.BMJ, 1993